Overview
Pharmaceutical

TSUMURA & CO.

Tsumura is Japan's leading manufacturer and distributor of Kampo (traditional Japanese herbal medicine) pharmaceutical products, offering over 100 prescription-based ethical Kampo formulations for the medical market as well as OTC Kampo medicines and healthcare products such as bath herbs for consumers. The company maintains a vertically integrated value chain from cultivating and procuring crude herbal ingredients (medicinal herbs) to manufacturing standardized Kampo extract granules, ensuring stable supply and consistent quality. Tsumura's competitive strengths lie in its 130-year heritage, proprietary raw material sourcing network spanning Japan, China, and Laos, and its strategic positioning at the intersection of traditional Kampo medicine and modern Western medicine.

Market Cap
¥279B
US$1.78B
EV
¥394B
US$2.52B
Stock¥3,738▲+0.73%
US$1 = ¥156.80 (2026-10-23)
LTM EV/EBITDA
8.0
x
LTM EV/EBIT
9.7
x
LTM PER
9.2
x
LTM PBR
0.9
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-18.1%pt
100
Oct 24, 25 – Oct 23, 26StockTOPIX
MC → EV Bridge
279BUS$1.78BMarket Cap148BUS$947M+ Debt77.3BUS$493M− Cash7.38BUS$47.1M− Inv. Sec.52.0BUS$332M+ NCI394BUS$2.52BEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
130US$826M'22/3140US$893M'23/3151US$962M'24/3181US$1.15B'25/3193US$1.23B'26/3
EBITDA 5Y (¥B)
31.1US$198M'22/331.0US$198M'23/330.3US$193M'24/350.7US$324M'25/347.5US$303M'26/3
Net Income 5Y (¥B)
18.8US$120M'22/316.5US$105M'23/316.7US$107M'24/332.4US$207M'25/328.1US$179M'26/3
Capital Structure
69%
31%
EquityD/E 0.45xDebt
Liquidity vs Debt 5Y (¥B)▼ Net Debt
CashInv. Sec.Debt
77.7US$496M49.7US$317M'22/3106US$675M79.7US$508M'23/393.3US$595M64.7US$413M'24/383.5US$533M70.8US$451M'25/391.6US$584M136US$865M'26/3
Shareholders
Top 10 hold 48.2%
1
The Master Trust Bank of Japan, Ltd. (Trust Account)
15.65%
2
BOCHK FOR PING AN LIFE INSURANCE COMPANY OF CHINA LTD (MUFG Bank, Ltd.)
10.20%
3
STATE STREET BANK AN D TRUST COMPANY 505001 (Standing Proxy: Mizuho Bank, Ltd.)
6.12%
4
Custody Bank of Japan, Ltd. (Trust Account)
5.46%
5
BRIGHT RIDE LIMITED (Standing Proxy: Mita Securities Co., Ltd.)
2.25%
6
TSUMURA & CO. Employee Stock Ownership Association
2.01%
7
MUFG Bank, Ltd.
1.79%
8
BNYM AS AGT/CLTS 10PERCENT (Standing Proxy: MUFG Bank, Ltd.)
1.75%
9
Nomura Trust and Banking Co., Ltd. (Investment Trust Account)
1.70%
10
JP MORGAN CHASE BANK 385781 (Standing Proxy: Mizuho Bank, Ltd.)
1.31%
Management
8 officers
Terukazu KATO
Representative Director, President, CEO (Chief Executive Officer)
Apr 1986 Joined the Company Aug 2001 Director and President, TSUMURA USA, INC. Jan 2006 General Manager, Public Relations Department, the Company Apr 2007 Executive Officer, General Manager, Corporate Communications Office, the Company Jun 2011 Director, Executive Officer, General Manager, Corporate Communications Office, the Company Jun 2012 Representative Director, President, the Company Jun 2015 Representative Director, President, Executive Officer, the Company Jun 2019 Representative Director, President, CEO, the Company (current)
1963-08-26
Kei SUGII
Director, COO (Chief Operating Officer)
Apr 1994 Joined Mitsubishi Yuka Engineering Co., Ltd. (now Mitsubishi Chemical Engineering Corporation) Jan 2006 Joined Accenture K.K. May 2009 Joined the Company Apr 2013 General Manager, Logistics Planning Department, the Company Apr 2016 General Manager, SCM Planning Department, the Company Apr 2017 Executive Officer, General Manager, Shenzhen Tsumura Pharmaceutical Co., Ltd. Apr 2018 Executive Officer, Chairman and General Manager, Shenzhen Tsumura Pharmaceutical Co., Ltd. Apr 2020 Executive Officer, Head of Production Division, the Company Apr 2022 Co-COO, the Company Jun 2022 Director, Co-COO, the Company Apr 2026 Director, COO, and President, Ethical Pharmaceuticals Company, the Company (current)
1969-12-16
Hiroshi MIYAKE
Director
Apr 1973 Joined Mitsubishi Corporation Oct 2000 General Manager, Paper and Packaging Materials Department, Mitsubishi Corporation Apr 2001 Deputy General Manager, Materials Division, Mitsubishi Corporation Apr 2003 Deputy General Manager, Kansai Branch, Mitsubishi Corporation Apr 2005 Executive Officer, Mitsubishi Corporation; President, Mitsubishi Corporation GmbH (Germany); Assistant to Europe Block General Manager May 2009 Advisor, Tokai Pulp Co., Ltd. Jun 2009 Managing Executive Officer, Tokusyu Tokai Holdings Co., Ltd. Jun 2010 Senior Managing Director, Tokusyu Tokai Paper Co., Ltd. Jun 2014 Director, Senior Managing Executive Officer, Tokusyu Tokai Paper Co., Ltd. Jun 2015 Representative Director, Vice President, Tokusyu Tokai Paper Co., Ltd. Jun 2016 Advisor, Tokusyu Tokai Paper Co., Ltd. Oct 2016 Advisor, Nihon Tokai Industrial Paper Supply Co., Ltd. Jun 2018 Director, the Company (current)
1949-08-04
Tadashi OKADA
Director
Apr 1979 Joined Komatsu Ltd. Apr 2000 General Manager, Business Development Department, Komatsu Ltd. Apr 2003 Deputy General Manager, Komatsu (China) Investment Co., Ltd. Apr 2006 General Manager, Corporate Communications Department, Komatsu Ltd. Apr 2007 Executive Officer, General Manager, Corporate Communications Department, Komatsu Ltd. Apr 2008 Executive Officer, General Manager, Corporate Planning Office, Komatsu Ltd. Feb 2009 Executive Officer, Deputy Head, Industrial Machinery Business Division, Komatsu Ltd. Apr 2011 Managing Executive Officer, Head of Industrial Machinery Business Division, Komatsu Ltd. Apr 2014 Managing Executive Officer, in charge of Public Relations, CSR, General Affairs and Compliance, Komatsu Ltd. Jun 2017 Representative Director, Chairman, Qualica Inc. Jun 2020 Director, the Company (current)
1956-05-01
Mariko EGUCHI
Director
Apr 1988 Joined The Mitsubishi Bank, Ltd. (now MUFG Bank, Ltd.) Apr 1999 Joined Nikko Salomon Smith Barney Securities Co., Ltd. (now Citigroup Securities Co., Ltd.), Investment Banking Division, Vice President Aug 2006 Joined UBS Securities Japan Co., Ltd., Investment Banking Division, Director May 2008 Director, Corporate Communications and Branding, UBS Group May 2019 Joined LaSalle Investment Management K.K., Head of Public Relations, Asia Pacific Feb 2020 Joined Aflac Life Insurance Japan Ltd., Executive Officer, in charge of Public Relations Department and Social Contribution Promotion Office Jan 2024 Advisor, Aflac Life Insurance Japan Ltd. Jun 2025 Outside Director, Sigmaxyz Holdings, Inc. (current) Jun 2025 Director, the Company (current)
1966-03-13
Tomihiro NAGABUCHI
Director, Audit and Supervisory Committee Member
Apr 1987 Joined the Company Apr 2014 General Manager, Internal Audit Department, the Company Apr 2023 Executive Officer, the Company Jun 2023 Full-time Director, Audit and Supervisory Committee Member, the Company (current)
1964-09-25
Akemi MOCHIZUKI
Director, Audit and Supervisory Committee Member
Oct 1984 Joined Aoyama Audit Corporation (now PwC Japan LLC) Mar 1988 Registered as Certified Public Accountant Aug 1996 Joined Audit Corporation Tohmatsu (now Deloitte Touche Tohmatsu LLC) Jun 2001 Member (title later changed to Partner), Audit Corporation Tohmatsu Jul 2018 Outside Director, Audit Committee Member, NSK Ltd. Jul 2018 Member, Meisei Audit Corporation Jun 2019 Director, Audit and Supervisory Committee Member, the Company Jun 2021 Outside Audit & Supervisory Board Member, Asahi Kasei Corporation (current) Jul 2022 Audit & Supervisory Board Member (part-time), SBI Holdings, Inc. (current)
1954-06-10
Chieko TSUCHIYA
Director, Audit and Supervisory Committee Member
Apr 1993 Joined Citibank, N.A. Oct 2001 Registered as attorney-at-law in Japan; joined Sakai Hideyuki Law Office (Bingham Sakai Mimura Aizawa Foreign Law Joint Enterprise) Apr 2006 Registered as attorney in New York State Sep 2012 Legal Officer, International Atomic Energy Agency (IAEA) Apr 2015 Joined Anderson Mori & Tomotsune Apr 2016 Part-time Judge (Family Mediation Commissioner), Tokyo Family Court Jan 2019 Special Counsel, Anderson Mori & Tomotsune (current) Sep 2021 Consultant, Tilleke & Gibbins, Thailand Mar 2025 Outside Director, Audit and Supervisory Committee Member, Micronics Japan Co., Ltd. (current) Jun 2025 Director, Audit and Supervisory Committee Member, the Company (current)
1971-01-27
Large Shareholding Reports
Ping An Life Insurance Company of China, Ltd.
2026-10-06
10.00%→10.00%
Nomura Asset Management Co., Ltd.
2026-09-24
4.95%→4.70%
Nomura Asset Management Co., Ltd.
2025-11-20
5.95%→4.95%
Disclosures
No disclosures
Primary Source Filings
EDINET
2026-10-06
Large Shareholding Report
EDINET
2026-09-24
Large Shareholding Report
TDnet
2026-08-06
Q1 Earnings Flash
FY ending Mar 2027
EDINET
2026-06-23
Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2026-05-29
株主総会招集通知
TDnet
2026-02-06
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2025-11-20
Large Shareholding Report
EDINET
2025-11-11
Semi-Annual Securities Report
Period: Apr 2025 – Mar 2026
TDnet
2025-08-05
Q1 Earnings Flash
FY ending Mar 2026
EDINET
2025-06-24
Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2025-02-20
Q3 Earnings Flash
FY ending Mar 2025
TDnet
2025-02-06
Q3 Earnings Flash
FY ending Mar 2025
EDINET
2024-11-08
Semi-Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2024-08-05
Q1 Earnings Flash
FY ending Mar 2025
EDINET
2024-06-27
Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-02-07
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-08
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
EDINET
2023-08-04
Quarterly Securities Report
Period: Apr 2023 – Jun 2023
EDINET
2023-06-29
Annual Securities Report
Period: Apr 2022 – Mar 2023
EDINET
2023-02-06
Quarterly Securities Report
Period: Oct 2022 – Dec 2022
EDINET
2022-11-07
Quarterly Securities Report
EDINET
2022-08-04
Quarterly Securities Report
EDINET
2022-06-29
Annual Securities Report
EDINET
2022-02-07
Quarterly Securities Report
EDINET
2021-11-08
Quarterly Securities Report
EDINET
2021-08-06
Quarterly Securities Report
EDINET
2021-06-29
Annual Securities Report
EDINET
2021-02-08
Quarterly Securities Report
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →